India’s Tata Institute develops tablet for cancer recurrence prevention
Pharmaceutical Technology
FEBRUARY 29, 2024
India’s Tata Institute has developed a tablet combining resveratrol and copper that has the potential to prevent the recurrence of cancer.
Let's personalize your content